Suliman M - Search Results

1

Associations between circulating inflammatory markers and residual renal function in CRF patients.

Pecoits-Filho R, Heimbürger O, Bárány P, Suliman M, Fehrman-Ekholm I, Lindholm B, Stenvinkel P. Pecoits-Filho R, et al. Among authors: suliman m. Am J Kidney Dis. 2003 Jun;41(6):1212-8. doi: 10.1016/s0272-6386(03)00353-6. Am J Kidney Dis. 2003. PMID: 12776273

2

The long pentraxin PTX-3 in prevalent hemodialysis patients: associations with comorbidities and mortality.

Suliman ME, Qureshi AR, Carrero JJ, Bárány P, Yilmaz MI, Snaedal-Jonsdottir S, Alvestrand A, Heimbürger O, Lindholm B, Stenvinkel P. Suliman ME, et al. QJM. 2008 May;101(5):397-405. doi: 10.1093/qjmed/hcn019. Epub 2008 Feb 20. QJM. 2008. PMID: 18292098

3

Low serum fetuin-A concentration predicts poor outcome only in the presence of inflammation in prevalent haemodialysis patients.

Metry G, Stenvinkel P, Qureshi AR, Carrero JJ, Yilmaz MI, Bárány P, Snaedal S, Heimbürger O, Lindholm B, Suliman ME. Metry G, et al. Among authors: suliman me. Eur J Clin Invest. 2008 Nov;38(11):804-11. doi: 10.1111/j.1365-2362.2008.02032.x. Eur J Clin Invest. 2008. PMID: 19021697

4

Clinical and biochemical implications of low thyroid hormone levels (total and free forms) in euthyroid patients with chronic kidney disease.

Carrero JJ, Qureshi AR, Axelsson J, Yilmaz MI, Rehnmark S, Witt MR, Bárány P, Heimbürger O, Suliman ME, Alvestrand A, Lindholm B, Stenvinkel P. Carrero JJ, et al. Among authors: suliman me. J Intern Med. 2007 Dec;262(6):690-701. doi: 10.1111/j.1365-2796.2007.01865.x. Epub 2007 Oct 1. J Intern Med. 2007. PMID: 17908160

5

Plasma pentosidine and total homocysteine levels in relation to change in common carotid intima-media area in the first year of dialysis therapy.

Suliman ME, Stenvinkel P, Jogestrand T, Maruyama Y, Qureshi AR, Bárány P, Heimbürger O, Lindholm B. Suliman ME, et al. Clin Nephrol. 2006 Dec;66(6):418-25. doi: 10.5414/cnp66418. Clin Nephrol. 2006. PMID: 17176913

6

Hyperhomocysteinemia in chronic renal failure patients: relation to nutritional status and cardiovascular disease.

Suliman ME, Lindholm B, Bárány P, Bergström J. Suliman ME, et al. Clin Chem Lab Med. 2001 Aug;39(8):734-8. doi: 10.1515/CCLM.2001.122. Clin Chem Lab Med. 2001. PMID: 11592443 Review.

7

Hyperhomocysteinemia, nutritional status, and cardiovascular disease in hemodialysis patients.

Suliman ME, Qureshi AR, Bárány P, Stenvinkel P, Filho JC, Anderstam B, Heimbürger O, Lindholm B, Bergström J. Suliman ME, et al. Kidney Int. 2000 Apr;57(4):1727-35. doi: 10.1046/j.1523-1755.2000.00018.x. Kidney Int. 2000. PMID: 10760109

8

Effects of high-dose folic acid and pyridoxine on plasma and erythrocyte sulfur amino acids in hemodialysis patients.

Suliman ME, Divino Filho JC, Bàràny P, Anderstam B, Lindholm B, Bergström J. Suliman ME, et al. J Am Soc Nephrol. 1999 Jun;10(6):1287-96. doi: 10.1681/ASN.V1061287. J Am Soc Nephrol. 1999. PMID: 10361867 Clinical Trial.

9

Evidence of taurine depletion and accumulation of cysteinesulfinic acid in chronic dialysis patients.

Suliman ME, Anderstam B, Bergström J. Suliman ME, et al. Kidney Int. 1996 Nov;50(5):1713-7. doi: 10.1038/ki.1996.490. Kidney Int. 1996. PMID: 8914041 Clinical Trial.

10

Total, free, and protein-bound sulphur amino acids in uraemic patients.

Suliman ME, Anderstam B, Lindholm B, Bergström J. Suliman ME, et al. Nephrol Dial Transplant. 1997 Nov;12(11):2332-8. doi: 10.1093/ndt/12.11.2332. Nephrol Dial Transplant. 1997. PMID: 9394320

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results